The Relationship Between Immune Inflammation Index and Major Cardiovascular Adverse Events in Patients with Heart Failure with Reduced Ejection Fraction.-Reference-Cited by-同舟云学术

The Relationship Between Immune Inflammation Index and Major Cardiovascular Adverse Events in Patients with Heart Failure with Reduced Ejection Fraction.

Published:2024-05-14 Issue:1 Volume:7 Page:6-12
ISSN:2636-851X
Container-title:Ege Tıp Bilimleri Dergisi
language:
Short-container-title:

Author:

Bektaş Osman¹^ORCID,Akkaya Fatih¹^ORCID

Affiliation:

1. ORDU ÜNİVERSİTESİ, TIP FAKÜLTESİ

Abstract

Aim: We aimed to investigate whether systemic immune inflammation index (SII) has a predictive value in predicting prognosis and major adverse cardiovascular events such as exitus, stroke and hospitalization in heart failure patients with reduced ejection fraction (HFrEF). Methods: Patients over the age of 18 who applied to the cardiology and emergency outpatient clinics between January 2019 and January 2022 and diagnosed with HFrEF (Ejection Fraction

Publisher

Ege Tip Bilimleri Dergisi

Reference25 articles.

1. Ardahanli I, Celik M. Serum Uric Acid Levels among Patients who Died in Recent Year due to Heart Failure with Reduced Ejection Fraction. J Coll Physicians Surg Pak. 2020 Aug;30(8):780-784. doi: 10.29271/jcpsp.2020.08.780. PMID: 32893785.

2. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. EurHeartJ. 2021;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.

3. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev.2017;3(1):7-11. doi: 10.15420/cfr.2016:25:2

4. Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017;14(1):3038. doi: 10.1038/nrcardio.2016.163.

5. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269285. doi: 10.1038/s41569-019-0315-x.